Efficacy of Optison Echo Contrast to Detect Thrombus in Left Atrial Appendage

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT01721447

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Phase 4
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01721447
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01721447. Allocation not applicable; no masking; primary purpose diagnostic. Start 2013-06 (registry gives no type); primary completion 2018-05 (actual). Results posted on 2019-06-04.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy of Optison Echo Contrast to Detect Thrombus in Left Atrial Appendage
Acronym
DOLOP
Intervention (Drug)
Optison echocardiography contrast agent
Lead sponsor
University of Utah (class: other)

Record details

Record id
cardio:ct-nct01721447
Content hash
988f7e995f84a3153708bd6b868a082105734faa30df9910a3c7cdb36f09ba61